Company
ImmPACT Bio
Claim, correct or request removal
Record updated 17 September 2026
About
ImmPACT-Bio is pioneering a novel technology that enables Chimeric Antigen Receptor T-cell (CAR-T) therapy to differentiate cancerous from non-cancerous tissues impacting the safety of the treatment which is a major limitation to its effectiveness.
Loading relationship preview